These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7082932)

  • 1. Ta and T1 bladder cancer: location, recurrence and progression.
    Heney NM; Nocks BN; Daly JJ; Prout GR; Newall JB; Griffin PP; Perrone TL; Szyfelbein WA
    Br J Urol; 1982 Apr; 54(2):152-7. PubMed ID: 7082932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mucosal biopsies and postoperative urinary cytology in patients with bladder cancer.
    Gil-Salom M; Sánchez MC; Chuan P; Clar F; Santamaría J; García-Sisamón F
    Eur Urol; 1990; 17(4):281-5. PubMed ID: 2364965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer.
    Smith G; Elton RA; Beynon LL; Newsam JE; Chisholm GD; Hargreave TB
    Br J Urol; 1983 Dec; 55(6):665-9. PubMed ID: 6652436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of random mucosal biopsies in the management of superficial bladder cancer.
    Mufti GR; Singh M
    Eur Urol; 1992; 22(4):288-93. PubMed ID: 1490505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour location adjacent to the ureteric orifice in primary Ta/T1 bladder cancer is predictive of recurrence.
    Jancke G; Rosell J; Jahnson S
    Scand J Urol; 2016; 50(1):33-8. PubMed ID: 26202687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.
    Turan T; Efiloğlu Ö; Günaydin B; Özkanli Ş; Nikerel E; Atiş G; Çaşkurlu T; Yildirim A
    Int Braz J Urol; 2018; 44(2):267-272. PubMed ID: 29219283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder wash cytology at diagnosis of Ta-T1 bladder cancer is predictive for recurrence and progression.
    Jancke G; Rosell J; Chebil G; Jahnson S
    Urology; 2012 Sep; 80(3):625-31. PubMed ID: 22925239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer.
    Hermann GG; Horn T; Steven K
    J Urol; 1998 Jan; 159(1):91-4. PubMed ID: 9400444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up.
    Malmström PU; Busch C; Norlén BJ
    Scand J Urol Nephrol; 1987; 21(3):185-95. PubMed ID: 3433019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial bladder cancer: progression and recurrence.
    Heney NM; Ahmed S; Flanagan MJ; Frable W; Corder MP; Hafermann MD; Hawkins IR
    J Urol; 1983 Dec; 130(6):1083-6. PubMed ID: 6644886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
    Shariat SF; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Sawczuk I; Serretta V; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Wians F; Roehrborn CG; Lotan Y; Perrotte P; Benayoun S; Marberger MJ; Karakiewicz PI
    J Urol; 2005 May; 173(5):1518-25. PubMed ID: 15821471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.
    Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Hsu TH; Chang LS
    Br J Urol; 1996 Aug; 78(2):209-12. PubMed ID: 8813915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of stage O, grade I bladder cancer by cytology alone--is it acceptable?
    Morrison DA; Murphy WM; Ford KS; Soloway MS
    J Urol; 1984 Oct; 132(4):672-4. PubMed ID: 6471210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
    Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
    Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does voided urine cytology have biological significance?
    Tut VM; Hildreth AJ; Kumar M; Mellon JK
    Br J Urol; 1998 Nov; 82(5):655-9. PubMed ID: 9839579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.